ProfileGDS4718 / 1553961_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 69% 74% 86% 68% 71% 78% 80% 74% 74% 69% 69% 76% 69% 77% 68% 68% 73% 75% 73% 79% 73% 71% 65% 70% 70% 75% 72% 77% 71% 80% 74% 75% 75% 72% 78% 76% 76% 74% 77% 87% 72% 80% 78% 77% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.8156469
GSM549102patient 115, normal, homogenized [OPG study]7.168974
GSM549104patient 119, normal, homogenized [OPG study]8.673586
GSM549108patient 138, normal, homogenized [OPG study]6.6957568
GSM549119patient 077, normal, homogenized [OPG study]6.9537671
GSM549133patient 032, cancer, homogenized [OPG study]7.7723978
GSM549139patient 042, cancer, homogenized [OPG study]7.9228380
GSM549099patient 107, normal, homogenized [OPG study]7.143774
GSM549109patient 139, normal, homogenized [OPG study]7.1740574
GSM549110patient 046, normal, homogenized [OPG study]6.733369
GSM549114patient 063, normal, homogenized [OPG study]6.7430669
GSM549122patient 082, normal, homogenized [OPG study]7.3840376
GSM549134patient 033, cancer, homogenized [OPG study]6.7682969
GSM549136patient 036, cancer, homogenized [OPG study]7.6800677
GSM549140patient 044, cancer, homogenized [OPG study]6.7125468
GSM549111patient 047, normal, homogenized [OPG study]6.7363468
GSM549113patient 057, normal, homogenized [OPG study]7.1893573
GSM549132patient 031, cancer, homogenized [OPG study]7.3634775
GSM549137patient 038, cancer, homogenized [OPG study]7.1946373
GSM549142patient 047, cancer, homogenized [OPG study]7.5675679
GSM549100patient 110, normal, homogenized [OPG study]7.0415473
GSM549107patient 135, normal, homogenized [OPG study]6.9975271
GSM549115patient 068, normal, homogenized [OPG study]6.4705365
GSM549116patient 072, normal, homogenized [OPG study]6.8688870
GSM549120patient 078, normal, homogenized [OPG study]6.8878370
GSM549131patient 030, cancer, homogenized [OPG study]7.3966975
GSM549118patient 074, normal, homogenized [OPG study]7.050372
GSM549129patient 027, cancer, homogenized [OPG study]7.6177977
GSM549123patient 088, normal, homogenized [OPG study]6.9770571
GSM549124patient 006, cancer, homogenized [OPG study]7.8030780
GSM549126patient 015, cancer, homogenized [OPG study]7.2772874
GSM549128patient 025, cancer, homogenized [OPG study]7.4518175
GSM549103patient 117, normal, homogenized [OPG study]7.22875
GSM549117patient 073, normal, homogenized [OPG study]7.038172
GSM549138patient 041, cancer, homogenized [OPG study]7.6761478
GSM549141patient 045, cancer, homogenized [OPG study]7.5492776
GSM549130patient 028, cancer, homogenized [OPG study]7.3865276
GSM549101patient 111, normal, homogenized [OPG study]7.2504674
GSM549105patient 128, normal, homogenized [OPG study]7.4927177
GSM549106patient 134, normal, homogenized [OPG study]8.8915387
GSM549112patient 048, normal, homogenized [OPG study]7.0024172
GSM549125patient 011, cancer, homogenized [OPG study]7.8407180
GSM549127patient 024, cancer, homogenized [OPG study]7.7391578
GSM549135patient 035, cancer, homogenized [OPG study]7.6951377